ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2020

Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice.

Aline David-Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.